Joseph J Galligan - Net Worth and Insider Trading

Joseph J Galligan Net Worth

The estimated net worth of Joseph J Galligan is at least $330,605 dollars as of 2024-04-28. Joseph J Galligan is the Director, 10% Owner of BioCorRx Inc and owns about 440,807 shares of BioCorRx Inc (BICX) stock worth over $330,605. Details can be seen in Joseph J Galligan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph J Galligan has not made any transactions after 2023-03-29 and currently still holds the listed stock(s).

Transaction Summary of Joseph J Galligan

Joseph J Galligan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph J Galligan owns 4 companies in total, including RiverNorth/DoubleLine Strategic Opportunity Fund Inc (OPP) , DoubleLine Income Solutions Fund (DSL) , and Doubleline Opportunistic Credit Fund (DBL) among others .

Click here to see the complete history of Joseph J Galligan’s form 4 insider trades.

Insider Ownership Summary of Joseph J Galligan

Ticker	Comapny	Transaction Date	Type of Owner
OPP	RiverNorth/DoubleLine Strategic Opportunity Fund Inc	2016-09-27	other: Exec Comm Mbr: OPP Subadviser
DSL	DoubleLine Income Solutions Fund	2013-04-25	Exe. VP of Adviser to DSL
DBL	Doubleline Opportunistic Credit Fund	2012-01-26	other: Portfolio Manager of DBL
BICX	BioCorRx Inc	2023-03-29	director & 10 percent owner

Joseph J Galligan Latest Holdings Summary

Joseph J Galligan currently owns a total of 1 stock. Joseph J Galligan owns 440,807 shares of BioCorRx Inc (BICX) as of March 29, 2023, with a value of $330,605.

Latest Holdings of Joseph J Galligan

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BICX	BioCorRx Inc	2023-03-29	440,807	0.75	330,605

Holding Weightings of Joseph J Galligan

Joseph J Galligan Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph J Galligan has made a total of 1 transactions in BioCorRx Inc (BICX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BioCorRx Inc is the acquisition of 171,296 shares on March 29, 2023, which cost Joseph J Galligan around $299,768.

Insider Trading History of Joseph J Galligan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph J Galligan Trading Performance

GuruFocus tracks the stock performance after each of Joseph J Galligan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph J Galligan is -3.25%. GuruFocus also compares Joseph J Galligan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph J Galligan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph J Galligan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph J Galligan

Average Return

-49.36%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.54	-3.25	-0.99	-49.36
Relative Return to S&P 500(%)	0.02	-12.4	-7.45	-79.81

Joseph J Galligan Ownership Network

Ownership Network List of Joseph J Galligan

No Data

Ownership Network Relation of Joseph J Galligan

Joseph J Galligan Owned Company Details

What does RiverNorth/DoubleLine Strategic Opportunity Fund Inc do?

Who are the key executives at RiverNorth/DoubleLine Strategic Opportunity Fund Inc?

Joseph J Galligan is the other: Exec Comm Mbr: OPP Subadviser of RiverNorth/DoubleLine Strategic Opportunity Fund Inc. Other key executives at RiverNorth/DoubleLine Strategic Opportunity Fund Inc include other: Portfolio Manager Stephen Andrew O'neill , other: OFFICER OF THE INVT ADVISER Brian H Schmucker , and director & President Patrick W. Galley .

RiverNorth/DoubleLine Strategic Opportunity Fund Inc (OPP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of RiverNorth/DoubleLine Strategic Opportunity Fund Inc (OPP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RiverNorth/DoubleLine Strategic Opportunity Fund Inc (OPP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc (OPP)'s detailed insider trading history can be found in Insider Trading Tracker table.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc Insider Transactions

No Available Data

What does DoubleLine Income Solutions Fund do?

Who are the key executives at DoubleLine Income Solutions Fund?

Joseph J Galligan is the Exe. VP of Adviser to DSL of DoubleLine Income Solutions Fund. Other key executives at DoubleLine Income Solutions Fund include CHIEF COMPLIANCE OFFICER Youse Guia , AML Compliance Officer Lisa Chen , and other: Trustee John C. Salter .

DoubleLine Income Solutions Fund (DSL) Insider Trades Summary

Over the past 18 months, Joseph J Galligan made no insider transaction in DoubleLine Income Solutions Fund (DSL). Other recent insider transactions involving DoubleLine Income Solutions Fund (DSL) include a net purchase of 100 shares made by Youse Guia ,

In summary, during the past 3 months, insiders sold 0 shares of DoubleLine Income Solutions Fund (DSL) in total and bought 100 shares, with a net purchase of 100 shares. During the past 18 months, 0 shares of DoubleLine Income Solutions Fund (DSL) were sold and 100 shares were bought by its insiders, resulting in a net purchase of 100 shares.

DoubleLine Income Solutions Fund (DSL)'s detailed insider trading history can be found in Insider Trading Tracker table.

DoubleLine Income Solutions Fund Insider Transactions

No Available Data

What does Doubleline Opportunistic Credit Fund do?

Who are the key executives at Doubleline Opportunistic Credit Fund?

Joseph J Galligan is the other: Portfolio Manager of DBL of Doubleline Opportunistic Credit Fund. Other key executives at Doubleline Opportunistic Credit Fund include AML Compliance Officer Lisa Chen , other: Trustee John C. Salter , and AML Officer Jose Sarmenta .

Doubleline Opportunistic Credit Fund (DBL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Doubleline Opportunistic Credit Fund (DBL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Doubleline Opportunistic Credit Fund (DBL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Doubleline Opportunistic Credit Fund (DBL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Doubleline Opportunistic Credit Fund Insider Transactions

No Available Data

What does BioCorRx Inc do?

Who are the key executives at BioCorRx Inc?

Joseph J Galligan is the director & 10 percent owner of BioCorRx Inc. Other key executives at BioCorRx Inc include Vice President of Operations Thomas Patrick Welch , director & Chief Executive Officer Kent Emry , and director & Chief Financial Officer Lourdes Felix .

BioCorRx Inc (BICX) Insider Trades Summary

Over the past 18 months, Joseph J Galligan made 1 insider transaction in BioCorRx Inc (BICX) with a net purchase of 171,296. Other recent insider transactions involving BioCorRx Inc (BICX) include a net purchase of 184,522 shares made by Louis C. Lucido ,

In summary, during the past 3 months, insiders sold 0 shares of BioCorRx Inc (BICX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioCorRx Inc (BICX) were sold and 355,818 shares were bought by its insiders, resulting in a net purchase of 355,818 shares.

BioCorRx Inc (BICX)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioCorRx Inc Insider Transactions

No Available Data

Joseph J Galligan Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph J Galligan. You might contact Joseph J Galligan via mailing address: 333 South Grand Avenue, 18th Floor, Los Angeles Ca 90071.

Discussions on Joseph J Galligan

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.